氟喹诺酮类药物的研究进展

被引:9
作者
郭洪寅
机构
[1] 天津市武清区人民医院
关键词
氟喹诺酮类; 本品; 肺炎链球菌; 环丙沙星; 革兰阴性菌; 肺炎双球菌; 链球菌属; 药物; 曲伐沙星;
D O I
暂无
中图分类号
R978.1 [抗生素];
学科分类号
100705 ;
摘要
引用
收藏
页码:311 / 312
页数:2
相关论文
共 9 条
[1]  
A new fluroguinolones drugs grepafloxacin. Anon. Medical Letter on Drugs and Therapeutics . 1998
[2]  
Withdrawals without widesproead disaster. Hughes S. Scrip Magazine . 2000
[3]  
In vitro activity of quinolones and other antimicrobial agents aganist anaerobic becteria. Nord Ce. Clinical Infectious Diseases . 1996
[4]  
In vitro activity of gemifloxacin(SB 265805)against anaerobes. Goldstein EJC,Citron DM,WarrenY,et al. Antimicrobial Agents and Chemotherapy . 1999
[5]  
Approach the topmost evel for treatment of vespiratory tract infection. Hartmut L. Scriptorium . 1999
[6]  
In vitro activity of OPC-17116 against more than 6000 consecutive clinical isolates: a multi-centr intrenational study. Marco F,Tones RN,Hoban DT,et al. Journal of Antimicrobial Chemotherapy . 1994
[7]  
In vitro activities of gemifloxacin (SB 265805, LB 20304)against recent clinical isolates of chlamydia penumoniae. Robin Pm,Reznik T,Kutlin A,et al. Antimicrobial Agents and Chemotherapy . 1999
[8]  
In vitro activity of grepafloxacin(OPC17116)against anaerobic becteria. Wexler HM,Molitoris E,Finegold SM. Diagnostic Microbiology and Infectious Disease . 1994
[9]  
In vitro activity of grepafloxacin(OPC-17116) agains anaerobic bacteria. Wexler HM,Molitoris E,Finegold SM. Diagnostic Microbiology and Infectious Disease . 1994